Call Buying Activity in FireEye (FEYE) Targets Upside in Shares Amid M&A Chatter -Susquehanna

Go back to Call Buying Activity in FireEye (FEYE) Targets Upside in Shares Amid M&A Chatter -Susquehanna

May Call Buying Continues in FireEye (FEYE) Targeting 4.5% Upside in Shares -Susquehanna

May 4, 2020 1:54 PM EDT

Susquehanna options strategist Alison Edwards notes call buying activity in FireEye (NASDAQ: FEYE), as opening investors purchased 17k May 11 Calls. This adds to ~9k of the same option that traded on Friday. The investors open exposure to a move above $11 (up 4.5%) through... More

Pre-Open Stock Movers 04/29: (CMRX) (EAT) (GOOGL) Higher; (APRN) (TUP) (IRBT) Lower (more...)

April 29, 2020 9:14 AM EDT

Today's Pre-Open Stock Movers

RR Donnelley (NYSE: RRD) 29.6% HIGHER; reported Q1 EPS of $0.33, $0.37 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $1.41 billion versus the consensus estimate of $1.38 billion.

Blue Apron (NYSE: APRN) 25.2% LOWER; reported Q1 EPS of ($1.51), $0.01 worse than the analyst estimate of ($1.50). Revenue for the quarter came in at $101.9 million versus the consensus estimate of... More

FireEye, Inc (FEYE) PT Lowered to $12 at Barclays

April 29, 2020 7:36 AM EDT

Barclays analyst Saket Kalia lowered the price target on FireEye, Inc (NASDAQ: FEYE) to $12.00 (from $13.00) while maintaining a Equalweight rating.... More

FireEye, Inc (FEYE) PT Lowered to $12 at Wedbush

April 29, 2020 6:49 AM EDT

Wedbush analyst Dan Ives lowered the price target on FireEye, Inc (NASDAQ: FEYE) to $12.00 (from $15.00) while maintaining a Neutral rating.... More

FireEye, Inc (FEYE) PT Lowered to $18 at Stifel

April 29, 2020 5:15 AM EDT

Stifel analyst Gur Talpaz lowered the price target on FireEye, Inc (NASDAQ: FEYE) to $18.00 (from $20.00) while maintaining a Buy rating.... More

After-Hours Stock Movers 04/28: (RRD) (GOOGL) (WW) Higher; (IRBR) (F) (FEYE) Lower (more...)

April 28, 2020 5:46 PM EDT

Today's After-Hours Stock Movers

RR Donnelley (NYSE: RRD) 40% HIGHER; reported Q1 EPS of $0.33, $0.37 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $1.41 billion versus the consensus estimate of $1.38 billion.

Chimerix (NASDAQ: CMRX) 22.5% HIGHER; announced that the Company has received clearance from the U.S. Food and Drug Administration (FDA) for a rolling submission of its New Drug Application (NDA) for the approval of brincidofovir (BCV) as a medical countermeasure for smallpox.... More

FireEye (FEYE) Tops Q1 EPS by 2c; Guides Lower

April 28, 2020 4:12 PM EDT

FireEye (NASDAQ: FEYE) reported Q1 EPS of ($0.02), $0.02 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $225 million versus the consensus estimate of $221.28 million.

"I believe we performed exceptionally well in the first quarter, said Kevin Mandia, FireEye chief executive officer. We were able to... More